Details
New companies 2 · Follow-on 1
Stages: Series A 3
Baba $40M Series AMelius $20M Series ANatural $30M Series ARanked by rounds participated in, from announcements in Jul 31, 2026 – Oct 28, 2026. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 1
Stages: Series A 3
Baba $40M Series AMelius $20M Series ANatural $30M Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Series B 1, Undisclosed 1
Lumilab Undisclosed Pre-seedEfficient Computer >$97M Series B financing agreementsEnduroSat $205M Funding roundNew companies 3 · Follow-on 0
Stages: Seed 2, Undisclosed 1
Wuyuan Technology Undisclosed Registered equity investmentPhoton $4.5M Seed子午线光年 Undisclosed AngelNew companies 3 · Follow-on 0
Stages: Pre-seed 2, Series A 1
CapQuest $1M Pre-seederad $22M Series AXSquare Undisclosed Pre-seedNew companies 3 · Follow-on 0
Stages: Seed 2, Series B 1
Daytona $60M Series BSynthefy $6.5M SeedXpander $7.5M SeedNew companies 3 · Follow-on 0
Stages: Series A 2, Series B 1
Daytona $60M Series BBaselayer $35M Series ANatural $30M Series ANew companies 2 · Follow-on 1
Stages: Series B 2, Series A 1
Daytona $60M Series BRainmaker $100M Series BAyble Health $16M Series ANew companies 3 · Follow-on 0
Stages: Series B 2, Undisclosed 1
Even Healthcare $50M Series BMoonwalk Biosciences $70M Series BUltrahuman $70M Funding roundNew companies 2 · Follow-on 1
Stages: Series B 2, Series A 1
Town $108M Series BWispr Flow $280M Series BNatural $30M Series ANew companies 3 · Follow-on 0
Stages: Seed 2, Series B 1
Greptile $50M Series BHop Aero $11M SeedRobocurve $10M SeedNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
Tenstorrent $1.5B Series EA5X R$360M Series DHiddenLayer $100M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 3
CoComply £1.9M UndisclosedMedcotec >£2.4M FundingTickets for Good £3.9M Funding roundNew companies 3 · Follow-on 0
Stages: Series A 2, Series B 1
Greptile $50M Series BSanté $15M Series ASapiom $35M Series ANew companies 3 · Follow-on 0
Stages: Pre-seed 1, Series A 1, Series C+ 1
Tenstorrent $1.5B Series EFab2 $500M Series AMara $7M Pre-SeedNew companies 3 · Follow-on 0
Stages: Series A 2, Series B 1
Town $108M Series BTeal Health $22M Series AOurs Privacy $15M Series ANew companies 3 · Follow-on 0
Stages: Seed 1, Series A 1, Series C+ 1
Nouscom €120M Series DAptadir Therapeutics €40M SeedDialybrid €15M Series ANew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
Tenstorrent $1.5B Series EA5X R$360M Series DGimlet Labs $300M Series BNew companies 3 · Follow-on 0
Stages: Undisclosed 2, Pre-seed 1
Vrtx $3.6M Pre-seedOKX Undisclosed Strategic extensionYellow Card $40M StrategicNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series B 1
CapGrid ₹462.8M Pre-Series BDailyObjects Undisclosed Series CRiver Mobility $120M Series CNew companies 3 · Follow-on 0
Stages: Undisclosed 3
NEXTES ¥2B Syndicated term loanHenry ¥1.2B Venture debt and equityUnited Immunity ¥2.2B Private financingNew companies 3 · Follow-on 0
Stages: Series B 1, Series C+ 1, Undisclosed 1
Microbiotica £36M Series C first closeANote Music €2M Funding roundHackuity $19M Series BNew companies 3 · Follow-on 0
Stages: Series A 2, Series B 1
Beff Inc. ~¥300M Series A final closeQBITech Co., Ltd. ~¥600M Series BOptQC Corp. ¥7B Series A2New companies 3 · Follow-on 0
Stages: Series B 2, Series A 1
RapidCanvas $29M Series BRezolv $12.5M Series AAcrab $130M Series BNew companies 3 · Follow-on 0
Stages: Seed 1, Series B 1, Undisclosed 1
North.cloud $60M Series BAutopoiesis Sciences $11M SeedMainstay >$18M FundingNew companies 3 · Follow-on 0
Stages: Pre-seed 1, Seed 1, Series A 1
Sprout Family CA$3.6M SeedBird & Be $13M Series ABlair Health CA$4.2M Pre-seedNew companies 2 · Follow-on 1
Stages: Seed 1, Series A 1, Series B 1
Otter Health $8M SeedSunbound $24M Series AOutmarket AI $34.5M Series BNew companies 3 · Follow-on 0
Stages: Series C+ 2, Series A 1
OMass Therapeutics $310M Series CSling Therapeutics, Inc. $123M Series CSolstice Oncology $225M Series ANew companies 3 · Follow-on 0
Stages: Series C+ 2, Series A 1
Abby Care $82M Series CBasalt Health $20M Series AThyme Care >$125M Series ENew companies 3 · Follow-on 0
Stages: Series A 2, Series C+ 1
Stand $70M Series CBuywander $21M Series AQueen One $25M Series ANew companies 2 · Follow-on 1
Stages: Series A 1, Series B 1, Series C+ 1
OMass Therapeutics $310M Series CAnaCardio €62.5M Series BBreye Therapeutics €67.5M Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.